The Special Situations Report cover image

Avis Budget Group Loses Its Turnaround CEO - The Special Situations Report Episode #6

The Special Situations Report

00:00

Potential Acquisition of Springworks Therapeutics by Merck Group

This chapter delves into the rumored acquisition of Springworks Therapeutics by Merck Group, emphasizing the impact of this deal on the company’s stock and product lineup. It also explores Merck’s prior acquisition of Myres Bio and provides insights into the leadership team's expertise at Springworks.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app